课题基金 / 基金详情

Basic and Clinical study on endocrine therapy of gynecologic diseases targeting aromatase

Basic and Clinical study on endocrine therapy of gynecologic diseases targeting aromatase
芳香酶靶向治疗妇科疾病内分泌的基础与临床研究
批准号:
16209049
负责人:
SHOZU Makio
金额:
$24.79万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2007

项目摘要

项目成果

SHOZU Makio的其他基金

相似基金

相关文献

中文摘要
翻译
近年来,随着晚婚或未婚的趋势,子宫内膜异位症、子宫肌瘤和子宫腺肌病等雌激素依赖性妇科疾病的发病率增加并恶化。女性年龄越大,排卵越困难。我们已经证明芳香化酶抑制剂是这些雌激素依赖性疾病以及特定排卵障碍(PCOS)的内分泌治疗的理论分子靶点。在这里,我们研究了芳香化酶抑制剂的治疗机制,并显示了芳香化酶抑制剂在治疗上述情况中可能的临床用途。在平滑肌瘤细胞中,芳香化酶的表达增强增加了原位雌激素,这可能促进了自身的增殖。在平滑肌瘤细胞中MAPK通路的缺乏激活也有助于通过减少Egr-1而增强细胞增殖,从而导致Rb表达降低。IGF-1通过剥夺新合成的芳香酶进入溶酶体的运输而增强平滑肌瘤细胞中芳香酶的积累,这可能是通过IGF-1对mTOR的作用介导的。平滑肌瘤细胞芳香化酶表达存在种族差异。结果表明,局部应用由法倔唑或达那唑负载的透明质酸组成的药物递送系统成功地治疗了大鼠巧克力囊肿模型,而没有全身效应。法倔唑术前给予平滑肌瘤患者,谁给他们的研究同意。三分之二的患者在前4周内表现出体积减少25%,症状改善。另一种芳香酶抑制剂来曲唑在知情同意的情况下给予PCOS患者,发现来曲唑在诱导排卵方面与克罗米酚一样有效,并且与克罗米酚相比,对植入困难的患者可能更有益。
英文摘要
Estrogen-dependent gynecologic diseases such as endometriosis, uterine leiomyoma and adenomyosis has been increased and worsened with a recent trend to late- or un-marriage in life. The older women become, the more difficult she ovulate. We have shown that an aromatase inhibitor(s) is a theoretical molecular target of endocrine therapy of these estrogen-dependent diseases as well as a specific ovulatory failure (PCOS). Here we examined therapeutic mechanisms of an aromatase inhibitor and showed the possible clinical usefulness of an aromatase inhibitor for management of the situations described earlier. In leiomyoma cells, enhanced expression of aromatase increased in situ estrogen, which possibly promoted the proliferation of their own. Absent activation of MAPK pathway in leiomyoma cells also contributed to enhanced cell proliferation through the reduction in Egr-1, resulting in low Rb expression. IGF-1 enhanced accumulation of aromatase in leiomyoma cells by deprivation of trafficking newly synthesized aromatase into lysosome, probably mediated by IGF-1 action on mTOR. There was a racial difference in aromatase expression of leiomyoma cells. It was shown that local application of a drug delivery system composed of fadrozole- or danazole-loaded hyaluronic acid successfully treated rat chocolate cyst model without systemic effect. Fadrozole was preoperatively administered to leiomyoma patients, who gave their consent for the study. Two third of patients showed reduction in volume by 25% with an improvement of symptoms, within the first 4 weeks. Another inhibitor of aromatase, letrozole, was administered to PCOS patients with an informed consent and found the letrozole was as effective as clomiphene in terms of ovulation induction and might be more beneficial to patients with implantation difficulty compared to clomiphene.
期刊论文(131)
专著(0)
科研奖励(0)
会议论文
Treatment of endometriosis by aromatase inhibitors.
通过芳香酶抑制剂治疗子宫内膜异位症。
DOI: --
发表时间: 2008
期刊: Obstet gynecol. 75(1)
影响因子: --
作者: [Shozu M, Usui H, Omoto A, Tsuruoka N.]
通讯作者: Tsuruoka N.
排卵障害-アロマターゼ阻害剤の不妊治療への応用 PCOS・ホルモン依存性癌患者における排卵誘発
排卵障碍 - 芳香酶抑制剂在不孕症治疗中的应用 PCOS/激素依赖性癌症患者的排卵诱导
DOI: --
发表时间: 2007
期刊: 医学のあゆみ 223・1
影响因子: --
作者: [Takahiko, Hamasaki, Nobuhiro, Tanaka, Naosuke, Kamei, Osamu, Ishida, Shinobu, Yanada, Kazuyoshi, Nakanishi, Koji, Nishida, Yoshiaki, Oishi, Seiichi, Kawamata, Norio, Sakai, Mistuo, Ochi, 生水真紀夫]
通讯作者: 生水真紀夫
アロマターゼ欠損症
芳香酶缺乏症
DOI: --
发表时间: 2007
期刊: 産婦人科の実際 56・8
影响因子: --
作者: [生水真紀夫, 木原真紀, 川野みどり, 松井英雄]
通讯作者: 松井英雄
不妊治療と多胎妊娠
不孕症治疗和多胎妊娠
DOI: --
发表时间: 2007
期刊: 千葉県医師会雑誌 59
影响因子: --
作者: [Hara T, Matsumura-Arioka Y, Ohtani K, Nakamura M., 生水 真紀夫]
通讯作者: 生水 真紀夫
共 94 条
    Getting genetic information from IVF media for noninvasive prenatal genetic screening
    • 批准号:
      15K15594
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.25万
    • 财政年份:
      2015
    • 负责人:
      SHOZU Makio
    • 依托单位:
    Aromatase induces ovulation via a reduction of follicular androgen and its application for infertility treatment
    • 批准号:
      25253092
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $24.88万
    • 财政年份:
      2013
    • 负责人:
      SHOZU Makio
    • 依托单位:
    Effects of metformin on endometrial cell in PCOS patients
    • 批准号:
      25670694
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2013
    • 负责人:
      SHOZU Makio
    • 依托单位:
    Progestogen prevents hypoxic-ischemic encephalopathy of neonatal rats
    • 批准号:
      23659772
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2011
    • 负责人:
      SHOZU Makio
    • 依托单位:
    国内基金
    海外基金
    去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
    • 批准号:
      31970691
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2019
    • 负责人:
      张胜萍
    • 依托单位:
    TM9SF4调控非小细胞肺癌细胞凋亡机制研究
    • 批准号:
      31900527
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2019
    • 负责人:
      孙磊
    • 依托单位:
    丹参酮ⅡA联合miR-29b inhibitor调控TGF-β1 / Smad3协同促进肌腱功能修复的机制研究
    • 批准号:
      81702135
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2017
    • 负责人:
      卢荟
    • 依托单位:
    ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究